Lines of Business
Drug Development Program
- 632 patient accruals in 2010
- Drug Development Programs located in London, Nashville, Oklahoma, and Florida
- 20,000 square-foot outpatient facility
- Full pharmacokinetic and pharmacodynamic capabilities
- 100 first-to-man trials
Research Consortium
- Approximately 700 community-based oncologists located in 25 states
- SCRI serves in the sponsor roles for sites
- SCRI holds the IND
- Participation in investigator-initiated trials only
- Non-exclusive contract
- No core services
Strategic Sites
- Exclusive agreements with SCRI
- Participation in industry-sponsored and investigator-initiated trials
- Site Support Services
- Represents 55,000 new patients annually in oncology
- Represents 54,000 new patients in non-oncology
Global Services
- Project Management
- Clinical Monitoring
- Medical Monitoring
- Data Management
- Biostatistics
- Safety
- Medical Writing
- Quality Assurance
- Facilitation of Data Safety Monitoring
- Regulatory Affairs
Digg
Del.icio.us
Yahoo
Google
Newsvine